Tocovid SupraBio is a neuroprotective agent. This means that it is able to protect the brain cells to minimize damage to the brain.
Tocovid is recommended for use in mini stroke patients because statistics show that 1 in 10 patients that have had a mini stroke can go on to have stroke as early as one week. So if the patients already have Tocovid in their system, should they go on to have a stroke, they can minimize damage to their brain cells. Minimisation of brain cell damage is vital because our brain cells are very important to us - once they are dead, they are dead, they do not regrow.
This protection is important as we know that disability occurs from brain damage. Being able to protect any cells during stroke can make a big difference in disability terms for a patient.
Mini stroke patients are the people that urgently require Tocovid. However, many of us are at high risk for stroke (e.g. high blood pressure, high cholesterol etc. ). Some people do not have the warning sign (mini stroke) before they have stroke. It is beneficial for one to be on Tocovid to provide the early protection before anything happens.
Chat with our AI personalities